Liothyronine shortage — CA supply status & alternatives

Liothyronine

—

🇦🇺 AUST R 12520 · Aspen Pharmacare Australia Pty Ltd

In supply · Australia

Teva-Liothyronine

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$41.19DPMQ A$100.28details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Liothyronine

Brand names	Teva-Liothyronine

Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper

Controlled substance	No

Marketing-authorisation holders	ACCORD-UK LIMITED, TEVA UK LIMITED, MERCURY PHARMA GROUP LIMITED, STRIDES PHARMA UK LIMITED +4 more

Registrations on file	11

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$41.19

AEMP

Dispensed (DPMQ)

A$100.28

incl. fees

Pack

liothyronine sodium 20 microgram tablet, 100

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$0.23

Acquisition

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

4 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Valary Lab Private LimitedPeptido GMBHAzico Biophore India PVT LTDMacleods Pharmaceuticals LTD

Manufacturing countries: India, Germany · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

LIOTHYRONINE SODIUM

SUN PHARMACEUTICAL INDUSTRIES INC · Dec 2023

Class IIdetails ↗

🇺🇸

LIOTHYRONINE SODIUM

SUN PHARMACEUTICAL INDUSTRIES INC · Oct 2023

Class IIdetails ↗

🇺🇸

LIOTHYRONINE SODIUM

SUN PHARMACEUTICAL INDUSTRIES INC · Oct 2023

Class IIdetails ↗

🇺🇸

Liothyronine Sodium Usp For Prescription Compounding

American Pharmaceutical Ingredients LLC · Feb 2018

Class IIdetails ↗

🇺🇸

Liothyronine Sodium (T3) Active Pharmaceutical Ingredient Pa

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

🇺🇸

LIOTHYRONINE SODIUM

SigmaPharm Laboratories LLC · Apr 2014

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders11 registrations · 8 MA holders

Product	Strength	Form	Market	MA holder	Status
Liothyronine Sodium 20micrograms	20MICROGRAM	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
Liothyronine Sodium	20 MICROGRAM	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
Liothyronine Sodium Bp 20micrograms	20MICROGRAM	tablet	🇬🇧 GB	MERCURY PHARMA GROUP LIMITED	Active
Liothyronine Sodium	5 MICROGRAM	tablet	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
Liothyronine Sodium	10 MICROGRAM	tablet	🇬🇧 GB	STRIDES PHARMA UK LIMITED	Active
Liothyronine Sodium	20 MCG	tablet	🇬🇧 GB	SIGMAPHARM LABORATORIES INTERNATIONAL LIMITED	Active
Liothyronine Sodium	25ug/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Liothyronine Sodium	5ug/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
Liothyronine Sodium	50ug/1	tablet	🇺🇸 US	TEVA PHARMACEUTICALS USA, INC.	Active
TERTROXIN Liothyronine sodium 20microgram tablet bottle	20microgram	—	🇦🇺 AU	Aspen Pharmacare Australia Pty Ltd	Active
Liothyronine Sodium	10ug/mL	injection	🇺🇸 US	XGen Pharmaceuticals DJB, Inc.	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.